Improving Screening and Therapy for Hispanic/Latinx at Risk for CKD
NCT ID: NCT05734989
Last Updated: 2025-04-20
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
59 participants
OBSERVATIONAL
2023-05-18
2025-04-04
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Completion of the project will hopefully slow progression of kidney disease among Hispanic/Latino(a) patients in Durham, and the information gained will allow the investigators to eventually perform the intervention on a larger scale.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Duke Cardiometabolic Prevention Clinic's Impact on High-risk Cardiovascular Patients With Uncontrolled Risk Factors
NCT07117695
Diabetes CKD Lifestyle Technology Study
NCT02266823
Personalized Diabetic Kidney Disease Risk Info to Initiate and Maintain Health Behavior Changes
NCT01377688
Feasibility of Reducing Cardiovascular Disease Risk Factors in Hispanics Through a Family-Based Community Intervention
NCT05322876
Diabetes Prevention Program for Obese Latino Youth
NCT02039141
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Hispanic/Latinx patients at risk for CKD
Adult patients in the Hispanic/Latinx Durham community screened for CKD
BP
Blood pressure measurements and HbA1c tests will be conducted to identify participants with or at risk for high blood pressure and/or Type 2 Diabetes. Those identified will be referred to PCP for follow up/treatment.
HbA1c
HbA1c will screen to identify patients with Type 2 diabetes
PCPs caring for Hispanic Latinx patients screened for CKD in the Durham Community
Primary Care Providers (PCPs) caring for Hispanic Latinx patients who agree to use the study guidelines and interventions for screening and monitoring their patients for CKD.
PCP Guidelines for Screening and Monitoring Hispanic/Latinx patients for CKD
Guidelines will be developed and provided to PCPs to use with their Hispanic/Latinx patients with or at risk for CKD.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
BP
Blood pressure measurements and HbA1c tests will be conducted to identify participants with or at risk for high blood pressure and/or Type 2 Diabetes. Those identified will be referred to PCP for follow up/treatment.
HbA1c
HbA1c will screen to identify patients with Type 2 diabetes
PCP Guidelines for Screening and Monitoring Hispanic/Latinx patients for CKD
Guidelines will be developed and provided to PCPs to use with their Hispanic/Latinx patients with or at risk for CKD.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Self-identifying as Hispanic/Latinx ethnicity.
Exclusion Criteria
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
National Institute on Minority Health and Health Disparities (NIMHD)
NIH
Duke University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Matthew Sinclair, MD
Role: PRINCIPAL_INVESTIGATOR
Duke University
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Duke University Medical Center
Durham, North Carolina, United States
Countries
Review the countries where the study has at least one active or historical site.
Provided Documents
Download supplemental materials such as informed consent forms, study protocols, or participant manuals.
Document Type: Informed Consent Form
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
Pro00112455
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.